Dermatology Times

🌟 Today is #WorldPsoriasisDay. Join us in advancing care and improving outcomes for patients with psoriasis. Stay updated on the latest psoriasis news, insights, and resources at Dermatology Times: https://lnkd.in/gxRcR7PE

💡 EXPERT INSIGHTS: Vivian Shi, MD, discussed the #EczemaAwarenessMonth theme: "Creative ways to manage your eczema," providing unconventional alternatives to traditional eczema management and discussing their role on patients’ well-being. 🖇 Read more: https://lnkd.in/gRcQyfw3

📰 FROM OUR PUBLICATION: In a series of roundtable events, leading dermatologists and their local peers tackled some of the most challenging cases of acne. Heather Woolery-Lloyd, MD, led a discussion with a team of dermatology clinicians centered around 2 challenging acne cases. 🖇 Read more: https://lnkd.in/ghrF-f-4

📰 FROM OUR PUBLICATION: Alexa Hetzel, MS, PA-C, was joined by colleagues Andrew Mastro, MS, PA-C; TJ Chao, MPAS, PA-C; and Terry Faleye, MPAS, PA-C, to discuss the treatment landscape for the management of plaque psoriasis. 🖇 Read more: https://lnkd.in/gzzrBdm5

🌟 Welcome to this week's edition of Dermatology Times' LinkedIn newsletter! Last week, we traveled to Las Vegas, Nevada, to attend and cover the 44th Annual Fall Clinical Dermatology Conference. Review insights from #FallClinical24 and more in our first Skin-Sights: Conference Insights edition. ⬇️ AND: Join our community of more than 10,300 dermatology and industry professionals receiving curated skin news every week by subscribing to our newsletter today.

📚 STUDY FINDINGS: A study on hidradenitis suppurativa found a 23% prevalence of inflammatory arthritis in HS patients, with increased risks linked to IBD, hypertension, and family history. 🖇 Read more: https://lnkd.in/gChf6E-c

💡 EXPERT INSIGHTS: Christophe Bourdon, chief executive officer of LEO Pharma, discusses LEO Pharma’s recent expansive dermatology profile and key takeaways from data presented at #EADV24. 🖇 Read more: https://lnkd.in/gHHuj9Ch

👥 DAY 4 RECAP: Catch up on Dermatology Times' coverage from the fourth and final day of #FallClinical24. Explore insights Christopher Bunick, MD, PhD; glynis ablon, MD; Eingun James Song, MD, FAAD; and Emmy Graber, MD, MBA. https://lnkd.in/geHcXZrq

🌟👥 LIVE FROM LAS VEGAS: #FallClinical24 brought together the brightest minds in dermatology against the lively backdrop of Las Vegas. This year’s conference was packed with fresh insights, innovative treatments, and essential pearls aimed at advancing clinical practice. Review our recap of expert insights from the meeting, including takeaways from interviews with Aaron S. Farberg, MD; Christopher Bunick, MD, PhD; Emmy Graber, MD, MBA; James Q. Del Rosso, DO; Eingun James Song, MD, FAAD; Joel M Gelfand MD MSCE; Mona Shahriari, MD, FAAD; Raj Chovatiya, MD, PhD, MSCI; and Shawn Kwatra, MD. https://lnkd.in/gJN9TN89

👥 CONFERENCE HIGHLIGHTS: Bristol Myers Squibb presented the results of the phase 3b/4 PSORIATYK SCALP trial at #FallClinical24. The data, showcased in a poster, highlighted the efficacy and safety of deucravacitinib (Sotyktu) in patients with moderate to severe scalp psoriasis, demonstrating significant improvements in clinical outcomes compared to placebo. 🖇 Read more: https://lnkd.in/gPSXi6NG